Article
MBD2 Ablation Impairs Lymphopoiesis and Impedes Progression and Maintenance of T-ALL
12 Jan 2018
Abstract excerpt
Abstract Aberrant DNA methylation patterns in leukemia might be exploited for therapeutic targeting. In this study, we employed a genetically deficient mouse model to explore the role of the methylated DNA binding protein MBD2 in normal and malignant hematopoiesis. MBD2 ablation led to diminished lymphocytes. Functional defects of the lymphoid compartment were also observed after in vivo reconstitution of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
